Skip to main content
Advancing detection and response capacities for emerging and re-emerging pathogens in Africa.
Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis.
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply.
Has artemisinin resistance emerged in Africa?
Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.
Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity.
Antimalarial drug resistance in Africa: the calm before the storm?
Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.
Artefenomel: a promising new antimalarial drug.
A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.